Phibro Animal Health (PAHC) Assets Average (2014 - 2026)
Phibro Animal Health (PAHC) posted quarterly Assets Average of $1.4 billion for Q1 2026, up 9.52% year-over-year from $1.3 billion in Q1 2025, and up 2.14% quarter-over-quarter from $1.4 billion in Q4 2025.
Phibro Animal Health (PAHC) Assets Average (2014 - 2026) Analysis & Trends
Phibro Animal Health's Assets Average history runs 13 years deep, the most recent figure standing at $1.4 billion for Q1 2026.
- In Q1 2026, Assets Average rose 9.52% year-over-year to $1.4 billion; the TTM figure through Mar 2026 stood at $1.4 billion (up 9.52% YoY), while the FY2025 annual figure was $1.2 billion, up 19.94% from the prior year.
- Assets Average for Q1 2026 stood at $1.4 billion, up from $1.4 billion in the prior quarter.
- The five-year high for Assets Average was $1.4 billion in Q1 2026, with the low at $882.6 million in Q1 2022.
- The 5-year median for Assets Average is $974.2 million (2024), against an average of $1.1 billion.
- The sharpest annual moves came in 2024 and 2025: Assets Average gained 0.65% in 2024, then soared 40.95% in 2025.
- Phibro Animal Health's Assets Average stood at $955.1 million in 2022, then rose by 1.41% to $968.6 million in 2023, then increased by 16.24% to $1.1 billion in 2024, then climbed by 23.95% to $1.4 billion in 2025, then rose by 2.14% to $1.4 billion in 2026.
- Business Quant data shows PAHC's Assets Average at $1.4 billion in Q1 2026, $1.4 billion in Q4 2025, and $1.4 billion in Q3 2025.
Powered by 
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Haleon | 43.83 Bn | 42.86 Bn | - | 43.72 Bn |
| 2 | Teva Pharmaceutical Industries | 42.87 Bn | 39.22 Bn | 2.15 Bn | 39.95 Bn |
| 3 | Zoetis | 31.41 Bn | 29.73 Bn | 1.05 Bn | 15.12 Bn |
| 4 | Takeda Pharmaceutical | 28.55 Bn | 22.75 Bn | 5.10 Bn | 98.59 Bn |
| 5 | United Therapeutics | 22.08 Bn | 19.42 Bn | 683.80 Mn | 6.97 Bn |
| 6 | Viatris | 18.73 Bn | 17.84 Bn | 1.46 Bn | 35.94 Bn |
| 7 | Neurocrine Biosciences | 15.44 Bn | 15.05 Bn | 935.80 Mn | 5.13 Bn |
| 8 | Elanco Animal Health | 11.75 Bn | 11.22 Bn | 798.00 Mn | 13.39 Bn |
| 9 | Dr Reddys Laboratories | 10.11 Bn | 9.94 Bn | - | 5.97 Bn |
| 10 | Phibro Animal Health | 1.42 Bn | 1.35 Bn | 125.68 Mn | 1.43 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 1.43 Bn |
| Dec 31, 2025 | 1.40 Bn |
| Sep 30, 2025 | 1.37 Bn |
| Jun 30, 2025 | 1.34 Bn |
| Mar 31, 2025 | 1.30 Bn |
| Dec 31, 2024 | 1.13 Bn |
| Sep 30, 2024 | 974.24 Mn |
| Jun 30, 2024 | 980.61 Mn |
| Mar 31, 2024 | 975.87 Mn |
| Dec 31, 2023 | 968.62 Mn |
| Sep 30, 2023 | 967.96 Mn |
| Jun 30, 2023 | 968.41 Mn |
| Mar 31, 2023 | 963.63 Mn |
| Dec 31, 2022 | 955.11 Mn |
| Sep 30, 2022 | 940.04 Mn |
| Jun 30, 2022 | 923.94 Mn |
| Mar 31, 2022 | 882.57 Mn |
| Dec 31, 2021 | 842.50 Mn |
| Sep 30, 2021 | 838.68 Mn |
| Jun 30, 2021 | 823.17 Mn |